1. Market Research
  2. > Affichem - Product Pipeline Review - 2013

Affichem - Product Pipeline Review - 2013

  • June 2013
  • -
  • Global Markets Direct
  • -
  • 19 pages

Affichem - Product Pipeline Review - 2013


Summary


Global Market Direct’s pharmaceuticals report, “Affichem - Product Pipeline Review - 2013” provides data on the Affichem’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Affichem’s corporate website, SEC filings, investor presentations and featured press releases, both from Affichem and industry-specific third party sources, put together by Global Markets Direct’s team.


Scope


- Affichem - Brief Affichem overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Affichem human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Affichem with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Affichem’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.


Reasons to buy


- Evaluate Affichem’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Affichem in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Affichem’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Affichem.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Affichem and identify potential opportunities in those areas.

Table Of Contents

Affichem - Product Pipeline Review - 2013
Table of Contents 2
List of Tables 3
List of Figures 3
Affichem Snapshot 4
Affichem Overview 4
Key Information 4
Key Facts 4
Affichem - Research and Development Overview 5
Key Therapeutic Areas 5
Affichem - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Affichem - Pipeline Products Glance 9
Affichem - Early Stage Pipeline Products 9
Pre-Clinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
Affichem - Drug Profiles 11
AF-122 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
AF-130s 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
AF-243 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
AF-250s 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Affichem - Pipeline Analysis 15
Affichem - Pipeline Products by Therapeutic Class 15
Affichem - Pipeline Products by Route of Administration 16
Affichem - Locations And Subsidiaries 17
Head Office 17
Other Locations and Subsidiaries 17
Appendix 18
Methodology 18
Coverage 18
Secondary Research 18
Primary Research 18
Expert Panel Validation 18
Contact Us 19
Disclaimer 19

List of Tables


Affichem, Key Information 4
Affichem, Key Facts 4
Affichem - Pipeline by Indication, 2013 6
Affichem - Pipeline by Stage of Development, 2013 7
Affichem - Monotherapy Products in Pipeline, 2013 8
Affichem - Pre-Clinical, 2013 9
Affichem - Discovery, 2013 10
Affichem - Pipeline By Therapeutic Class, 2013 15
Affichem - Pipeline By Route of Administration, 2013 16
Affichem, Other Locations 17

List of Figures


Affichem - Pipeline by Indication, 2013 6
Affichem - Pipeline by Stage of Development, 2013 7
Affichem - Monotherapy Products in Pipeline, 2013 8
Affichem - Pipeline By Therapeutic Class, 2013 15
Affichem - Pipeline By Route of Administration, 2013 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.